Antibiotic treatment for nontuberculous mycobacterial lung disease

Young Ae Kang, Won Jung Koh

Research output: Contribution to journalReview article

20 Citations (Scopus)

Abstract

Pulmonary infections are the most frequent diseases caused by nontuberculous mycobacteria (NTM). Common causative organisms of pulmonary infection are slowly growing mycobacteria including Mycobacterium avium complex and Mycobacterium kansasii, and rapidly growing mycobacteria including Mycobacterium abscessus complex. Clinical concern has been raised over the increasing incidence of NTM lung disease combined with the poor treatment outcomes of these chronic infectious diseases. Since treatment guidelines of the American Thoracic Society/Infectious Disease Society of America were published in 2007 there have been continuous efforts to improve the outcomes of NTM lung disease, albeit slowly and with limitations. Here, we focus on recent advances in the antibiotic treatment of NTM lung disease.

Original languageEnglish
Pages (from-to)557-568
Number of pages12
JournalExpert Review of Respiratory Medicine
Volume10
Issue number5
DOIs
Publication statusPublished - 2016 May 3

Fingerprint

Nontuberculous Mycobacteria
Lung Diseases
Mycobacterium
Anti-Bacterial Agents
Communicable Diseases
Mycobacterium kansasii
Mycobacterium avium Complex
Lung
Infection
Chronic Disease
Guidelines
Incidence

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Pulmonary and Respiratory Medicine
  • Public Health, Environmental and Occupational Health

Cite this

@article{ee20cf544c29427ba65eafe806ea8369,
title = "Antibiotic treatment for nontuberculous mycobacterial lung disease",
abstract = "Pulmonary infections are the most frequent diseases caused by nontuberculous mycobacteria (NTM). Common causative organisms of pulmonary infection are slowly growing mycobacteria including Mycobacterium avium complex and Mycobacterium kansasii, and rapidly growing mycobacteria including Mycobacterium abscessus complex. Clinical concern has been raised over the increasing incidence of NTM lung disease combined with the poor treatment outcomes of these chronic infectious diseases. Since treatment guidelines of the American Thoracic Society/Infectious Disease Society of America were published in 2007 there have been continuous efforts to improve the outcomes of NTM lung disease, albeit slowly and with limitations. Here, we focus on recent advances in the antibiotic treatment of NTM lung disease.",
author = "Kang, {Young Ae} and Koh, {Won Jung}",
year = "2016",
month = "5",
day = "3",
doi = "10.1586/17476348.2016.1165611",
language = "English",
volume = "10",
pages = "557--568",
journal = "Expert Review of Respiratory Medicine",
issn = "1747-6348",
publisher = "Expert Reviews Ltd.",
number = "5",

}

Antibiotic treatment for nontuberculous mycobacterial lung disease. / Kang, Young Ae; Koh, Won Jung.

In: Expert Review of Respiratory Medicine, Vol. 10, No. 5, 03.05.2016, p. 557-568.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Antibiotic treatment for nontuberculous mycobacterial lung disease

AU - Kang, Young Ae

AU - Koh, Won Jung

PY - 2016/5/3

Y1 - 2016/5/3

N2 - Pulmonary infections are the most frequent diseases caused by nontuberculous mycobacteria (NTM). Common causative organisms of pulmonary infection are slowly growing mycobacteria including Mycobacterium avium complex and Mycobacterium kansasii, and rapidly growing mycobacteria including Mycobacterium abscessus complex. Clinical concern has been raised over the increasing incidence of NTM lung disease combined with the poor treatment outcomes of these chronic infectious diseases. Since treatment guidelines of the American Thoracic Society/Infectious Disease Society of America were published in 2007 there have been continuous efforts to improve the outcomes of NTM lung disease, albeit slowly and with limitations. Here, we focus on recent advances in the antibiotic treatment of NTM lung disease.

AB - Pulmonary infections are the most frequent diseases caused by nontuberculous mycobacteria (NTM). Common causative organisms of pulmonary infection are slowly growing mycobacteria including Mycobacterium avium complex and Mycobacterium kansasii, and rapidly growing mycobacteria including Mycobacterium abscessus complex. Clinical concern has been raised over the increasing incidence of NTM lung disease combined with the poor treatment outcomes of these chronic infectious diseases. Since treatment guidelines of the American Thoracic Society/Infectious Disease Society of America were published in 2007 there have been continuous efforts to improve the outcomes of NTM lung disease, albeit slowly and with limitations. Here, we focus on recent advances in the antibiotic treatment of NTM lung disease.

UR - http://www.scopus.com/inward/record.url?scp=84962050744&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84962050744&partnerID=8YFLogxK

U2 - 10.1586/17476348.2016.1165611

DO - 10.1586/17476348.2016.1165611

M3 - Review article

C2 - 26967761

AN - SCOPUS:84962050744

VL - 10

SP - 557

EP - 568

JO - Expert Review of Respiratory Medicine

JF - Expert Review of Respiratory Medicine

SN - 1747-6348

IS - 5

ER -